Anna Ollerstam is a Senior Director in Cardiovascular, Renal, and Metabolism Safety at AstraZeneca in Sweden. They previously served as a Principal Research Scientist and Discovery Project Leader at LEO Pharma, overseeing the management of discovery projects. At AstraZeneca R&D, they held the roles of Discovery Toxicologist and Associate Principal Scientist, where they represented toxicology in cross-functional project teams and addressed safety issues with new drug candidates. Anna has an MSc in Biology, Physiology from Lund University and a PhD in Physiology from Uppsala University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices